Imagine a patient with several health problems moving through a modern medical system. She may see a family doctor, a specialist, a hospital team, a pharmacist and perhaps a community service. Each professional may be highly skilled. Each organisation may own sophisticated software. Yet the patient can still find herself repeating the same story, carrying information between appointments, waiting for records to arrive and trying to understand who is responsible for what. The individual parts work well, but the journey doesn’t.

Vaccines can prevent serious illness, disability and death, but their benefits depend on people actually receiving them. When vaccination rates fall, the usual question is how to support more people to get vaccinated. Yet that question may be too simple. A reminder, a conversation, a financial incentive or a more convenient clinic can all help, but they do not necessarily help everyone in the same way. That is the central insight emerging from a major analysis led by Dr Sarah Davies and Dr Clare French, both of the University of Bristol, and colleagues. To go beyond asking whether broad categories such as “education” or “improved access” work, the researchers took apart vaccine uptake interventions to examine their individual ingredients. It is a little like studying recipes: knowing that a cake tastes good is useful, but knowing which ingredients make the difference is far more helpful if you want to create a better cake.

What if depression is best understood as a process that gathers momentum, rather than a fixed illness that simply appears once enough symptoms have accumulated? A difficult week becomes persistent stress. Persistent stress demands more coping. Coping becomes exhausting. Sleep, appetite, activity and relationships begin to change. Those changes can then create fresh stress, pushing a person further down a self-reinforcing spiral.

For many men, a conversation about prostate cancer begins long before they enter a doctor’s office. It may begin when a brother mentions a test, when a friend describes a frightening diagnosis, or when a family member dies from cancer. For Black men, those conversations carry particular urgency. Prostate cancer affects them much more often, yet knowing that a disease is dangerous does not automatically mean people have the information, confidence, or trusted relationships needed to make decisions about screening.

High blood pressure or hypertension is often called the silent killer, because the symptoms that it does cause beyond headache (such as nervousness, sleep disturbance, and poor exercise tolerance) have not typically been linked to elevated blood pressure. Over the years when blood pressure remains uncontrolled it damages the heart, brain, kidneys, and blood vessels and impairs their function. Millions of people take blood pressure medication every day for the purpose of lowering their blood pressure to normal levels. For many, those medicines work well, however for others, the numbers on the blood pressure monitor remain stubbornly high despite taking several different antihypertensive drugs. This frustrating situation leaves patients at increased risk for preventable health problems (such as stroke, and heart failure) and both them and their doctors searching for better answers.

For decades, respiratory viruses seemed to follow a familiar seasonal script. As autumn cooled into winter, influenza returned, respiratory syncytial virus, better known as RSV, filled pediatric wards, and a collection of other viruses circulated alongside them. Hospitals could never predict the season perfectly, but experience provided a rough map of what was coming. Then COVID-19 arrived, and the map stopped matching the territory.

A lottery ticket is small enough to slip into a pocket, but the forces that shape gambling behavior can stretch across families, neighborhoods, shopping districts, and entire communities. A Massachusetts study led by Dr. Kendra Pugh asks an important but deceptively simple question: when gambling becomes risky or problematic, how much depends on the person, and how much depends on the place?

A mosquito’s whine is easy to dismiss as a minor irritation. Yet some mosquitoes carry one of humanity’s oldest and deadliest diseases. Malaria is caused by microscopic Plasmodium parasites, but those parasites depend on Anopheles mosquitoes to move from one human host to another. Understanding the mosquito, therefore, is an important part of understanding the disease. Every new genetic reference gives researchers another way to investigate what makes these insects effective vectors, how populations differ, and how their biology may shape transmission. Two recent genome announcements involving Dr. Shimaa Ghazal and student researchers at Phillips Exeter Academy add new genetic resources for studying two particularly important malaria vectors: Anopheles gambiae and Anopheles stephensi.

To most of us, a vial of blood looks like a simple container of biological truth, a snapshot of what was happening inside a person at the moment the needle entered their arm. Scientists can measure its proteins, read genetic material, hunt for signs of disease, and feed the resulting data into increasingly powerful analytical systems. Yet that vial has a history. How long did it sit before processing? At what temperature? What kind of tube held it? Was it spun, transported, frozen, thawed, or stored? Each step may quietly change what researchers later believe they are seeing.

For more than four decades, HIV has challenged some of the brightest scientific minds in the world. Tremendous progress has transformed HIV from what was once almost always a fatal infection into a condition that can often be managed with modern medicines. Preventive treatments have also become increasingly effective. Yet millions of people continue to become infected every year, particularly in regions where access to healthcare remains limited. A safe, effective preventive HIV vaccine remains one of the greatest goals in global medicine because it has the potential to provide large-scale, long-lasting prevention for large numbers of high-risk populations.